IDYA Financials
Ideaya Biosciences Inc - Financial statements & key metrics
Stock Price
$33.91
Market Cap
$2.85B
EPS
$-1.28
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$7.00M
Gross Profit
-
Operating Income
-
Net Income
$-274.48M
EPS (Diluted)
$-3.36
Balance Sheet Highlights
Total Assets
$1.12B
Total Liabilities
$64.94M
Shareholders Equity
-
Cash & Equivalents
$84.38M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-247.58M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
-43.9%
Operating Margin
-8.7%
Net Margin
-0.5%
ROE
-0.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is IDYA revenue?
IDYA's most recent quarterly revenue was $7.00M. Annual revenue can be calculated by summing the four most recent quarters.
Is IDYA profitable?
IDYA reported a loss of $274.48M in the most recent quarter. The net profit margin is -0.5%.
What is IDYA market cap?
IDYA has a market capitalization of $2.85B, making it a mid-cap stock.
Does IDYA have debt?
View IDYA's balance sheet for debt information.
What is IDYA cash flow?
Cash flow data is available in the full financial statements.